Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Jun 24 | Jun 23 | Jun 22 | Jun 21 |
Cash Equivalents | 238.50 | 339.63 | 281.40 | 417.96 |
Short Term Investments | 13.37 | 12.56 | 7.46 | - |
Cashand Short Term Investments | 251.87 | 447.61 | 326.86 | 468.91 |
Accounts Receivable- Trade Net | 85.33 | 115.71 | 83.44 | 59.43 |
Total Receivables Net | 87.05 | 201.19 | 157.94 | 137.62 |
Total Inventory | 109.11 | 140.96 | 117.62 | 119.84 |
Other Current Assets Total | 76.19 | 5.17 | 5.13 | - |
Total Current Assets | 524.22 | 796.10 | 608.04 | 727.14 |
Property/ Plant/ Equipment Total- Net | 131.53 | 173.27 | 149.62 | 139.99 |
Intangibles Net | 0.96 | 0.94 | 0.04 | 0.12 |
Long Term Investments | 1.90 | 2.25 | 2.60 | 2.95 |
Note Receivable- Long Term | 93.93 | 98.22 | 99.41 | 19.68 |
Other Long Term Assets Total | 41.82 | 30.41 | 28.41 | 96.28 |
Total Assets | 794.36 | 1,101.19 | 888.12 | 986.16 |
Accounts Payable | 167.00 | 237.04 | 172.08 | 128.76 |
Current Portof LT Debt/ Capital Leases | 2.68 | 3.12 | 2.83 | 4.75 |
Other Currentliabilities Total | 49.23 | 28.43 | 30.06 | 89.17 |
Total Current Liabilities | 218.91 | 303.90 | 231.90 | 238.97 |
Capital Lease Obligations | 6.88 | 8.88 | 0.00 | 2.86 |
Total Long Term Debt | 6.88 | 8.88 | 0.00 | 2.86 |
Total Debt | 9.56 | 12.00 | 2.83 | 7.61 |
Other Liabilities Total | 30.33 | 37.52 | 39.73 | 40.62 |
Total Liabilities | 256.12 | 350.30 | 271.63 | 282.45 |
Common Stock Total | 16.60 | 16.60 | 16.60 | 16.60 |
Retained Earnings( Accumulated Deficit) | 521.64 | 723.16 | 588.76 | 675.98 |
Total Equity | 538.24 | 750.89 | 616.49 | 703.71 |
Total Liabilities Shareholders' Equity | 794.36 | 1,101.19 | 888.12 | 986.16 |
Total Common Shares Outstanding | 1.66 | 1.66 | 1.66 | 1.66 |
Tangible Book Valueper Share Common Eq | 323.66 | 451.79 | 371.37 | 423.87 |
Cash | - | 95.42 | 38.00 | 50.95 |
Prepaid Expenses | - | 1.17 | 0.49 | 0.77 |
Property/ Plant/ Equipment Total- Gross | - | 293.74 | 280.07 | 252.43 |
Accumulated Depreciation Total | - | -120.47 | -130.45 | -112.44 |
Accrued Expenses | - | 35.31 | 26.93 | 16.29 |
Notes Payable/ Short Term Debt | - | 0.00 | 0.00 | 0.00 |
Additional Paid- In Capital | - | 11.13 | 11.13 | 11.13 |
Procter & Gamble Health Dividend Procter & Gamble Health Bonus Procter & Gamble Health News Procter & Gamble Health AGM Procter & Gamble Health Rights Procter & Gamble Health Splits Procter & Gamble Health Board Meetings Procter & Gamble Health Key Metrics Procter & Gamble Health Shareholdings Procter & Gamble Health Profit Loss Procter & Gamble Health Cashflow Procter & Gamble Health Q1 Results Procter & Gamble Health Q2 Results Procter & Gamble Health Q3 Results Procter & Gamble Health Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks